van Staa TP - Search Results

1

Development of predictive genetic tests for improving the safety of new medicines: the utilization of routinely collected electronic health records.

Wing K, Douglas I, Bhaskaran K, Klungel OH, Reynolds RF, Pirmohamed M, Smeeth L, van Staa TP. Wing K, et al. Among authors: van staa tp. Drug Discov Today. 2014 Apr;19(4):361-6. doi: 10.1016/j.drudis.2013.11.003. Epub 2013 Nov 14. Drug Discov Today. 2014. PMID: 24239729

2

Use of inhaled corticosteroids and the risk of non-fatal acute myocardial infarction.

de Vries F, Pouwels S, Bracke M, Lammers JW, Leufkens H, Klungel O, van Staa T. de Vries F, et al. J Hypertens. 2008 Jan;26(1):124-9. doi: 10.1097/HJH.0b013e3282f0ab4a. J Hypertens. 2008. PMID: 18090549

3

What is the harm-benefit ratio of Cox-2 inhibitors?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Int J Epidemiol. 2008 Apr;37(2):405-13. doi: 10.1093/ije/dym296. Epub 2008 Feb 8. Int J Epidemiol. 2008. PMID: 18263647

4

Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.

de Vries F, Pouwels S, Bracke M, Lammers JW, Klungel O, Leufkens H, van Staa T. de Vries F, et al. Br J Clin Pharmacol. 2008 Apr;65(4):580-6. doi: 10.1111/j.1365-2125.2007.03077.x. Epub 2008 Feb 12. Br J Clin Pharmacol. 2008. PMID: 18279472 Free PMC article.

5

Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Pharmacoepidemiol Drug Saf. 2008 May;17(5):475-84. doi: 10.1002/pds.1568. Pharmacoepidemiol Drug Saf. 2008. PMID: 18322905

6

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

van Staa TP, Leufkens HG, Zhang B, Smeeth L. van Staa TP, et al. PLoS Med. 2009 Dec;6(12):e1000194. doi: 10.1371/journal.pmed.1000194. Epub 2009 Dec 8. PLoS Med. 2009. PMID: 19997499 Free PMC article.

7

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.

Gallagher AM, Smeeth L, Seabroke S, Leufkens HG, van Staa TP. Gallagher AM, et al. Among authors: van staa tp. PLoS One. 2011;6(12):e28157. doi: 10.1371/journal.pone.0028157. Epub 2011 Dec 2. PLoS One. 2011. PMID: 22164237 Free PMC article.

8

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.

Bhaskaran K, Douglas I, Evans S, van Staa T, Smeeth L. Bhaskaran K, et al. BMJ. 2012 Apr 24;344:e2697. doi: 10.1136/bmj.e2697. BMJ. 2012. PMID: 22531797 Free PMC article.

9

Will the revolution in genetics improve healthcare?

Smeeth L, van Staa T. Smeeth L, et al. BMJ. 2012 Jul 20;345:e4651. doi: 10.1136/bmj.e4651. BMJ. 2012. PMID: 22822006 No abstract available.

10

The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.

Van Den Ham HA, Klungel OH, Leufkens HG, Van Staa TP. Van Den Ham HA, et al. Among authors: van staa tp. J Thromb Haemost. 2013 Jan;11(1):107-15. doi: 10.1111/jth.12041. J Thromb Haemost. 2013. PMID: 23088617 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters